The emerging treatment of the medication represents a significant development in the handling of the condition. Different to existing medications, tirzepatide affects two pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide720303.blogerus.com/64101185/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment